Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
Cancers
|
April 13, 2023
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
Pierre Leblond, Emmanuelle Tresch-Bruneel, Alicia Probst, et al.
Plos One
|
January 4, 2013
HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study
Sophie Perrin, Jonathan Cremer, Olivia Faucher, et al.
Journal De Mycologie Medicale
|
January 16, 2026
Probable disseminated cryptococcosis relapse in a patient with Hodgkin's lymphoma treated with induction therapy resumption and autologous stem cell transplant
Hugo Bes-Berlandier, Jan Patrick Stellmann, Simar Berro, et al.
Plos One
|
July 26, 2012
HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" study
Sophie Perrin, Jonathan Cremer, Patrice Roll, et al.
Ebiomedicine
|
July 14, 2022
Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2
Jean-Sélim Driouich, Maxime Cochin, Franck Touret, et al.
Clinical Immunology (Orlando, Fla.)
|
January 13, 2024
Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients
Alexandra Y Kreins, Emma Roux, Juanita Pang, et al.
World Journal of Hepatology
|
December 12, 2018
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
Dominique Salmon, Pascale Trimoulet, Camille Gilbert, et al.
Nature
|
July 23, 2020
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
Pauline Maisonnasse, Jérémie Guedj, Vanessa Contreras, et al.
Nature Communications
|
August 30, 2022
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
Romain Marlin, Delphine Desjardins, Vanessa Contreras, et al.
Plos Computational Biology
|
March 17, 2021
SARS-CoV-2 viral dynamics in non-human primates
Antonio Gonçalves, Pauline Maisonnasse, Flora Donati, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
Cancers
|
April 13, 2023
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
Pierre Leblond, Emmanuelle Tresch-Bruneel, Alicia Probst, et al.
Plos One
|
January 4, 2013
HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study
Sophie Perrin, Jonathan Cremer, Olivia Faucher, et al.
Journal De Mycologie Medicale
|
January 16, 2026
Probable disseminated cryptococcosis relapse in a patient with Hodgkin's lymphoma treated with induction therapy resumption and autologous stem cell transplant
Hugo Bes-Berlandier, Jan Patrick Stellmann, Simar Berro, et al.
Plos One
|
July 26, 2012
HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" study
Sophie Perrin, Jonathan Cremer, Patrice Roll, et al.
Ebiomedicine
|
July 14, 2022
Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2
Jean-Sélim Driouich, Maxime Cochin, Franck Touret, et al.
Clinical Immunology (Orlando, Fla.)
|
January 13, 2024
Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients
Alexandra Y Kreins, Emma Roux, Juanita Pang, et al.
World Journal of Hepatology
|
December 12, 2018
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
Dominique Salmon, Pascale Trimoulet, Camille Gilbert, et al.
Nature
|
July 23, 2020
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
Pauline Maisonnasse, Jérémie Guedj, Vanessa Contreras, et al.
Nature Communications
|
August 30, 2022
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
Romain Marlin, Delphine Desjardins, Vanessa Contreras, et al.
Plos Computational Biology
|
March 17, 2021
SARS-CoV-2 viral dynamics in non-human primates
Antonio Gonçalves, Pauline Maisonnasse, Flora Donati, et al.
Page
of 13